Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity

NCT04361474 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

120

Enrollment

NETWORK

Sponsor class

Conditions

Budesonide
Olfaction Disorders
SARS-CoV-2
Anosmia

Interventions

DRUG: Budesonide Nasal
OTHER: Physiological serum

Sponsor

Fondation Ophtalmologique Adolphe de Rothschild

Collaborators

[object Object]